NOVOCURE LIMITED
Last · —$13.84-0.46 (-3.22%)live · yahoo · 1h ago
Vol 335.6K ≈ 4.76M
MA10MA20MA50
Market cap$1.61B—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
Issuer
Legal nameNOVOCURE LIMITED
HQUnited States (US)
ListingUS NVCR
ISINJE00BYSS4X48
SectorHealthcare
IndustryMedical Equipment, Supplies & Distribution
SIC3841
CurrencyUSD
Entity registrysec:0001645113
CIK0001645113
Websitewww.novocure.com
Employees1,605
AddressNovoCure Ltd. No. 4 The Forum JE2 4UF, St. Helier
| Revenue | $357.6M |
|---|---|
| Operating income | $-78.0M |
| Net income | $-86.8M |
| Free cash flow | $-17.5M |
| Operating margin | -21.8% |
| Net margin | -24.3% |
| Return on equity | -25.7% |
| Period | 2026 |
Loading chart…
Upcoming earnings
THU.29OCT
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.23
Est. revenue
182.2M
Documents
FormReporting forFiledFlags
Showing 5 of 22 filings